Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men

Human Reproduction

Volumn 21, Issue 8, 2006, Pages 2033-2040

  Meriggiola, M Cristina ^a   Cerpolini, S ^a   Bremner, W J ^b   Mbizvo, M T ^a   Vogelsong, K M ^c   Martorana, G ^a   Pelusi, G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Acceptability; Male hormonal contraception; Testosterone

Indexed keywords

MALE CONTRACEPTIVE AGENT; NORETHISTERONE ENANTATE; TESTOSTERONE UNDECANOATE;

ADULT; AGE DISTRIBUTION; ANGER; APPETITE DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERECTILE DYSFUNCTION; HORMONAL CONTRACEPTION; HUMAN; HUMAN RELATION; INSOMNIA; IRRITABILITY; ITALY; LETHARGY; LIBIDO DISORDER; MALE; MALE SEXUAL DYSFUNCTION; MOOD DISORDER; PATIENT ATTITUDE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESPONSIBILITY; SCREENING TEST; SNORING; SWEAT GLAND DISEASE; VOLUNTEER;

EID: 33747890676     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del094     Document Type: Article

References (51)

1. Anderson RA and Baird DT (2002) Male contraception. Endocr Rev 23,735-762.
2. Anderson RA, Baneroft J and Wu FC (1992) The effects of exogenous testosterone on sexuality and mood of normal men. J Clin Endocrinol Metab 75,1503-1507.
3. Anderson RA, Kinniburgh D and Baird DT (2002) Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception. J Clin Endocrinol Metab 87,3640-3649.
4. Anonymous (1997) Trust introduces new translation criteria. Med Outcomes Trust Bull 5,2-4.
5. Bagatell CJ, Heiman JR, Matsumoto AM, Rivier JE and Bremner WJ (1994) Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. J Clin Endocrinol Metab 79,561-567.
6. Balsswick JO (1972) Attitudes of lower class males toward taking a male birth control pill. Fam Coordinator 21,195-201.
7. Brady BM, Walton M, Hollow N, Kicman AT, Baird DT and Anderson RA (2004) Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception. Hum Reprod 19,2658-2667.
8. Brady BM, Amory JK, Perheentupa A, Zitzmann M, Hay CJ, Apter D, Anderson RA, Bremner WJ, Pollanen P, Nieschlag E et al. (2006) A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive. Hum Reprod 21,285-294.
9. Brislin RW (1970) Back-translation for cross-cultural research. J Cross-Cultural Psychol 1,185-216.
10. Clayton A, McGarvey E and Clavet G (1997) The changes in sexual functioning questionnaire (CSFQ): Development, reliability and validity. Psychopharmacol Bull 33,731-745.
11. Corty E, Althof S and Kurit D (1996) The reliability and validity of a sexual functioning questionnaire. J Sex Marital Ther 22,27-34.
12. Derogatis L (1997) The Derogatis interview for sexual functioning (DISF/ DISF-SR): An introductory report. J Sex Marital Ther 23,291-304.
13. Diller L and Hembree W (1977) Male contraception and family planning: A social and historical review. Fertil Steril 28,1271-1279.
14. Drennam M (1998) Reproductive health: New perspectives on men's participation. Popul Rep J, no. 46.
15. Ezeh AC, Seroussi M and Raggers H (1996) Men's Fertility, Contraceptive Use, and reproductive Preference. DHS Comparative Studies No. 18. Macro International, Calverton, MD.
16. Feiger A, Kiev A, Shrivastava RK, Wisselink PG and Wilcox CS (1996) Nefazodene vs sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function. J Clin Psychol 57,53-62.
17. Glasier AF, Anakwe R, Everington D, Martin CW, van der Spuy Z, Cheng L, Ho PC and Anderson RA (2000) Would women trust their partners to use a male pill? Hum Reprod 15,646-649.
18. Gough HG (1979) Some factors related to men's stated willingness to use a male contraceptive pill. J Sex Res 15,27-37.
19. Grady WR, Tanfer K, Billy JO and Lincoln-Hanson J (1996) Men's perception of their roles and responsibilities regarding sex, contraception, and childrearing. Fam Plan Perspect 28,221-226.
20. Hall MF (1971) Male attitudes to family planning education in Santiago, Chile. J Biosoc Sci 3,403-416.
21. Hay CJ, Brady BM, Zitzmann M, Osmanagaoglu K, Pollanen P, Apter D, Wu FC, Anderson RA, Nieschlag E, Devroey P et al. (2005) A multicentre phase IIb study of a novel combination of intramuscular androgen (testosterone decanaoate) and oral progestogen (etonogestrel) for male hormonal contraception. J Clin Endocrinol Metab 90,2042-2049.
22. Heinemann K, Saad F, Wiesemes M, White S and Heinemann L (2005a) Attitudes toward male fertility control: Results of a multinational survey on four continents. Hum Reprod 20,549-556.
23. Heinemann K, Sand F, Wiesemes M and Heinemann L (2005b) Expectations toward a novel male fertility control method and potential user types: results of a multinational survey. J Androl 26,155-162.
24. Herdman M, Fox-Rushby J and Badia X (1998) A model of equivalence in the cultural adaptation of HRQoL instruments: The universalist approach. Qual Life Res 7,323-335.
25. Hulton L and Falkingham J (1996) Male contraceptive knowledge and practice. What do we know? Reprod Health Matters 7,90-100.
26. Kamischke A and Nieschlag E (2004) Progress towards hormonal male contraception. Trends Pharmacol Sci 25,49-57.
27. Keith L, Keith D, Bussell R and Wells J (1975) Attitudes of men toward contraception. Arch Gynakol 220,89-97.
28. Keller A (1979) Contraceptive acceptability research: Utility and limitations. Stud Fam Plann 10,230-237.
29. Lorr M and McNair D (1980) Profile of Mood States. Bipolar Form. Educational and Industrial Testing S Service, San Diego, CA.
30. Ly LP, Liu PY and Handelsman DJ (2005) Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimen. Hum Reprod 20,1733-1740.
31. Martin CW, Anderson RA, Cheng L, Ho PC, van der Spuy Z, Smith KB, Glasier AF, Everington D and Baird DT (2000) Potential impact of hormonal male contraception: Cross-cultural implications for development of novel preparations. Hum Reprod 15,637-645.
32. Meriggiola MC and Bremner WJ (1997) Progestin-androgen combination regimens for male contraception. J Androl 18,240-244.
33. Meriggiola MC, Costantino A and Cerpolini S (2002) Recent advances in hormonal male contraception. Contraception 65,269-272.
34. Meriggiola MC, Farley TMM and Mbizvo MT (2003a) A review of androgen-progestin regimens for male contraception. J Androl 24,466-483.
35. Meriggiola MC, Costantino A, Cerpolini S, Bremner WJ, Huebler D, Morselli Labate AM, Kirsch B, Bertaccini A, Pelusi C and Pelusi G (2003b) Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal men. J Clin Endocrinol Metab 88,5818-5826.
36. Meriggiola MC, Costantino A, Saad F, D'Emidio L, Morselli Labate AM, Bertaccini A, Bremner WJ, Rudolph I, Ernst M, Kirsch B et al. (2005) Norethisterone enanthate plus testosterone undecanoate for male contraception: Effects of various injection intervals on spermatogenesis, reproductive hormones, testis and prostate. J Clin Endocrinol Metab 90,2005-2014.
37. Norusis M (1998) SPSS Inc. SPSS Base 8.0 User's and Applications Guides. SPSS Inc., Chicago, IL.
38. O'Leary MP, Fowler FJ, Lenderking WR, Barber B, Sagnier PP, Guess HA and Barry MJ (1995) A brief male sexual function inventory of urology. Urology 45,697-706.
39. Posner JK and Mbodji F (1989) Men's attitudes about family planning in Dakar, Senegal. J Biosoc Sci 21,279-291.
40. Potts M (1996) The myth of a male pill. Nat Med 2,398-399.
41. Reynolds C, Frank E, Thase M, Houck P, Jennings J, Howell J, Lilienfeld S and Kupfer D (1988) Assessment of sexual function in depressed, impotent and healthy men: Factor analysis of a brief sexual function questionnaire for men. Psychiatry Res 24,231-250.
42. Ringheim K (1995) Evidence for the acceptability of an injectable hormonal method for men. Fam Plann Perspect 27,123-128.
43. Ringheim K (1996) Whither methods for men? Emerging gender issues in contraception. Reprod Health Matters 7,79-89.
44. Rosen RC (1998) Sexual function assessment in the male: Physiological and self-report measures. Int J Impot Res 10,S59-S63.
45. Sjoegren B and Gottlieb C (2001) Testosterone for male contraception during one year: Attitudes, well-being and quality of sex life. Contraception 64,59-65.
46. Snedecor GW and Cochran WG (1989) Statistical Methods, 8th edn. Iowa State University Press, Ames.
47. United Nations Department of Economic and Social Affairs Population Division (2004) World Contraceptive Use 2003.
48. Von Eckardstein S and Nieschlag E (2002) Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: A phase II study. J Androl 23,419-425.
49. Waites GM (2003) Development of methods of male contraception: Impact of the World Health Organization Task Force. Fertil Steril 80,1-15.
50. Wang C and Swerdloff RS (2002) Male contraception. Best Prac Res Clin Obstet Gynaecol 16,193-203.
51. WHO (1980) Acceptability of drugs for male fertility regulation: A prospectus and some preliminary data. Contraception 21,121-132.